Jeffrey Humphrey

Jeffrey Humphrey, MD, brings extensive experience in the biopharmaceutical industry, having served as Chief Medical Officer at multiple companies, including Lantheus, Magenta Therapeutics, and Constellation Pharmaceuticals, a MorphoSys Company. Additionally, Jeffrey Humphrey co-founded Charged Biotherapeutics and has contributed to the governance of Cyteir Therapeutics as an Independent Member of the Board of Directors. Jeffrey Humphrey holds an A.B. in Mathematics, cum laude, from Harvard University and an M.D. in Medicine from Case Western Reserve University School of Medicine.